Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11474661 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
Condition: Leukemia
Intervention: Biological: BL22 immunotoxin

Study has passed its completion date and status has not been verified in more than two years.